Gene Therapies: Global Pathways to Bridge Innovation & Access

• Enabling early patient access to investigational gene therapies through global pre-approval pathways and compassionate use programs
• Supporting patient access to gene therapy treatment with managed and conditional post-approval models
• Strengthening safety, effectiveness, and global alignment by leveraging multi-stakeholder data and collaboration

Speakers:

Kent Christopherson

Head, Global Medical Affairs

Orchard Therapeutics